# Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients

> **NCT06983223** · NA · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 50 (actual)

## Conditions studied

- Vitamin B 12 Deficiency
- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DIETARY_SUPPLEMENT:** Sucrosomial® Vitamin B12
- **OTHER:** Placebo (Oral)

## Key facts

- **NCT ID:** NCT06983223
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-15
- **Primary completion:** 2025-12-03
- **Final completion:** 2025-12-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06983223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06983223, "Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06983223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*